What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.85%Below 5Y avg (3.85%)
Annual Rate
CNY 0.30Paid annual
Payout Ratio
71.2%Moderate
Payback Period
25.7 yr
Last Ex-Dividend
Jun 8, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
12.66BCNY
1.88B · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
11.79x
vs Conglomerates peers
Updated Aug 19, 2026
Revenue (TTM)
40.18BCNY
5.96B · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
3.14%
vs Conglomerates peers
Updated Aug 19, 2026
Beta
0.5060x
vs all stocks
Updated Aug 19, 2026
52-Week Change
2.37%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
12.66BCNY
1.88B · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
6.71BCNY
995.04M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
11.79x
vs Conglomerates peers
Updated Aug 19, 2026
Forward P/E
8.84x
vs Conglomerates peers
Updated Aug 19, 2026
PEG Ratio
-0.8841x
vs Conglomerates peers
Updated Aug 19, 2026
Price to Sales (TTM)
0.3152x
vs Conglomerates peers
Updated Aug 19, 2026
Price to Book (MRQ)
0.7679x
vs Conglomerates peers
Updated Aug 19, 2026
Enterprise to Revenue
0.1670x
vs Conglomerates peers
Updated Aug 19, 2026
Enterprise to EBITDA
2.13x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 1.6×.Updated Aug 19, 2026
Gross Margin
13.39%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 15.49%.Updated Aug 19, 2026
Profit Margin
3.14%
vs Conglomerates peers
Updated Aug 19, 2026
Operating Margin
5.34%
vs Conglomerates peers
Updated Aug 19, 2026
Return on Assets (TTM)
3.74%
vs Conglomerates peers
Updated Aug 19, 2026
Return on Equity (TTM)
9.51%
vs Conglomerates peers
Updated Aug 19, 2026
Revenue (TTM)
40.18BCNY
5.96B · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
24.48CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
8.90%
vs Conglomerates peers
Updated Aug 19, 2026
Gross Profit (TTM)
6.22BCNY
922.96M · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
4.19BCNY
620.85M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
1.26BCNY
187.35M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
-12.60%
vs Conglomerates peers
Updated Aug 19, 2026
Operating Cash Flow (TTM)
2.47BCNY
366.69M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
-102.76MCNY
-15.24M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing Annual Dividend Rate
0.3000CNYUpdated Aug 19, 2026
Trailing Annual Dividend Yield
3.85%
vs all stocks
Updated Aug 19, 2026
5-Year Average Dividend Yield
3.85%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
71.21%
vs Conglomerates peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 45.45%.Updated Aug 19, 2026
Minority Interest (Equity)
6.47BCNYFY2025 · Dec 31, 2025
Revenue
39.44BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
33.00BCNYFY2025 · Dec 31, 2025
Gross Profit
6.44BCNYFY2025 · Dec 31, 2025
Operating Income
2.88BCNY
427.03M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
3.01BCNYFY2025 · Dec 31, 2025
Income Tax Expense
803.99MCNYFY2025 · Dec 31, 2025
Net Income
2.21BCNYFY2025 · Dec 31, 2025
EBIT
3.29BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
4.19BCNYFY2025 · Dec 31, 2025
Research & Development
71.58MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
934.31MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
122.18MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
197.58MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
276.02MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.7900CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.6700CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
1.64BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
1.64BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
2.21BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-915.63MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
1.50BCNYFY2025 · Dec 31, 2025
Free Cash Flow
532.11MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
12.64BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
2.21BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
494.72MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-1.13BCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-72.79MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-966.01MCNYFY2025 · Dec 31, 2025
Net Acquisitions
21.34MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-46.93BCNYFY2025 · Dec 31, 2025
Sale of Investments
46.98BCNYFY2025 · Dec 31, 2025
Other Investing Activity
43.49MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-850.54MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
5.19BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-5.06BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-940.09MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-315.98MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-1.13BCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.63BSharesUpdated Aug 19, 2026
Float Shares
814.56MSharesUpdated Aug 19, 2026
% Held by Insiders
49.98%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
5.77%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
21.56BCNY
3.20B · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
13.25CNYUpdated Aug 19, 2026
Total Debt (MRQ)
8.98BCNY
1.33B · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.3888x
vs Conglomerates peers
Updated Aug 19, 2026
Current Ratio (MRQ)
2.24x
vs Conglomerates peers
Updated Aug 19, 2026
Book Value per Share (MRQ)
10.13CNYUpdated Aug 19, 2026
Total Assets
46.79BCNY
6.94B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
36.29BCNYFY2025 · Dec 31, 2025
Total Liabilities
24.06BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
10.49BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
5.21BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
18.84BCNYFY2025 · Dec 31, 2025
Cash
13.77BCNYFY2025 · Dec 31, 2025
Cash Equivalents
1.00BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
14.78BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
8.29BCNYFY2025 · Dec 31, 2025
Accounts Receivable
7.21BCNYFY2025 · Dec 31, 2025
Inventory
3.87BCNYFY2025 · Dec 31, 2025
Accounts Payable
11.71BCNYFY2025 · Dec 31, 2025
Short-term Debt
4.06BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
200.67MCNYFY2025 · Dec 31, 2025
Long-term Debt
5.10BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.63BCNYFY2025 · Dec 31, 2025
Retained Earnings
7.98BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
22.73BCNY
3.37B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
7.06CNYUpdated Aug 19, 2026
52-Week High
11.10CNYUpdated Aug 19, 2026
52-Week Change
2.37%
vs all stocks
Updated Aug 19, 2026
Beta
0.5060x
vs all stocks
Updated Aug 19, 2026
50-Day MA
7.57CNYUpdated Aug 19, 2026
200-Day MA
8.74CNYUpdated Aug 19, 2026
Avg 10-Day Volume
11.45MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
12.03MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
0.6600CNYUpdated Aug 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.08: grey zoneSignificant
Altman Z-Score: 2.08
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Market cap is $1.88B, above the global median of $1.15BNotable
Market cap (USD): 1,878,029,938.491Global Median: 1,146,734,693.424
Revenue is $5.96B, above the global median of $520.53MNotable